Ethicon Drops Sedasys PMA Appeal As FDA Agrees to “Expeditious” Review

Devices & Diagnostics Letter
A A
The FDA has agreed to review its denial of sedation system Sedasys, prompting Johnson & Johnson subsidiary Ethicon Endo-Surgery to drop an appeal.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00